Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03723928
Brief Title: S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

First Submitted : October 10, 2018
First Submitted that Met QC Criteria : October 25, 2018
First Posted : October 30, 2018

Last Update Submitted that Met QC Criteria : May 12, 2021
Last Update Posted : May 13, 2021